Smiths Medical 21-2863-24 - NEEDLE, GRIPPER PLUS, 22G X 1.25", Y-SITE, 12 EA/BX

Smiths Medical 21-2863-24 - NEEDLE, GRIPPER PLUS, 22G X 1.25", Y-SITE, 12 EA/BX

The Smiths Medical 21-2863-24 Gripper Plus Needle is a high-performance non-coring Huber needle designed for safe and reliable access to implanted ports. Engineered with a 22-gauge needle and a 1.25-inch length, this device supports consistent infusion therapy while minimizing patient discomfort and maintaining port integrity. The integrated Y-site enhances clinical flexibility, allowing simultaneous administration of medications or flushing without the need for multiple access points.

Designed with both patient safety and clinician efficiency in mind, the Gripper Plus system features a low-profile design and secure stabilization base that helps reduce movement during therapy. Its precision construction ensures smooth septum penetration, extending the life of implanted ports and supporting long-term treatment protocols such as chemotherapy, antibiotic therapy, and parenteral nutrition.

Key Benefits

The non-coring needle design protects the integrity of implanted port septums, reducing the risk of coring and extending device longevity. The integrated Y-site allows for dual access, improving workflow efficiency and reducing the need for repeated needle insertions. The ergonomic design enhances clinician control during placement, while the low-profile base improves patient comfort during extended wear.

Clear and secure connections help reduce the risk of leakage or disconnection, ensuring consistent and reliable infusion delivery. The device is also designed to support stable positioning, minimizing accidental dislodgement during patient movement.

Compatibility and Applications

This Gripper Plus needle is compatible with most standard implanted port systems used in oncology, long-term infusion therapy, and chronic disease management. It is commonly used in hospitals, outpatient infusion centers, oncology clinics, and home healthcare settings.

The Y-site configuration makes it particularly useful in situations requiring simultaneous infusion and flushing, such as chemotherapy administration, hydration therapy, or antibiotic delivery. Its design supports both intermittent and continuous infusion protocols.

Usage Guidelines

Before use, healthcare professionals should follow standard aseptic techniques and institutional protocols for port access. The site should be properly cleaned and prepared prior to needle insertion. The needle should be inserted at a perpendicular angle to the port septum to ensure proper placement and avoid damage.

Once inserted, the device should be secured using appropriate dressings to maintain stability. The Y-site should be used according to clinical requirements, ensuring proper flushing before and after medication administration. After use, the needle should be removed carefully and disposed of in accordance with sharps safety regulations.

Certifications and Safety Standards

The Smiths Medical Gripper Plus needle is manufactured in compliance with stringent medical device standards to ensure safety, reliability, and performance. It meets applicable regulatory requirements for sterile, single-use medical devices and is produced under quality-controlled manufacturing processes.

Each unit is individually packaged and sterilized to maintain product integrity until the point of use. The design supports infection control protocols by minimizing contamination risks during handling and use.

Comparison with Competitors

Compared to standard Huber needles, the Gripper Plus stands out due to its integrated Y-site, which enhances clinical flexibility and reduces the need for additional connectors or devices. Its low-profile design improves patient comfort compared to bulkier alternatives, making it more suitable for extended wear.

Additionally, the stabilization base offers improved security during therapy, reducing the likelihood of needle movement or dislodgement. While many competing products provide basic port access, the Gripper Plus combines comfort, safety, and functionality in a single device.

Typical User Profile and Application Scenarios

This product is ideal for healthcare professionals working in oncology units, infusion centers, and home healthcare environments. It is commonly used for patients requiring long-term intravenous therapies, including chemotherapy, parenteral nutrition, and antibiotic treatments.

Patients with implanted ports who require frequent or continuous access benefit from the needles design, as it minimizes discomfort and supports efficient treatment delivery. Clinicians appreciate its ease of use and reliability in demanding clinical settings.

Best Practices for Use and Maintenance

To ensure optimal performance, the needle should be used according to established clinical guidelines and replaced as recommended based on therapy duration. Proper dressing techniques should be applied to maintain needle stability and reduce infection risk.

Regular monitoring of the insertion site is essential to identify any signs of irritation, infection, or displacement. Flushing protocols should be followed carefully to maintain catheter patency and ensure consistent infusion flow.

Regulatory and Safety Information

This device is intended for single use only and should not be reused or re-sterilized. It must be handled and disposed of in accordance with local regulations for medical sharps. Healthcare providers should follow all institutional policies and procedures related to port access and infusion therapy.

Proper training in the use of Huber needles and implanted port systems is essential to ensure patient safety and effective treatment outcomes. Any adverse events or complications should be reported and managed according to clinical protocols.

How to Order

To place an order for the Smiths Medical 21-2863-24 Gripper Plus Needle 22G x 1.25 Inch with Y-Site, contact CIA Medical at (312) 275-5850. Our team is available to assist with product selection, bulk pricing, and delivery options to meet your facilitys needs.